07Apr/14

Santen announces Phase III results of sirolimus intravitreal injections in non … – News-Medical.net

Santen announces Phase III results of sirolimus intravitreal injections in non
News-Medical.net
Santen Inc., the U.S. subsidiary of global ophthalmic pharmaceutical company Santen Pharmaceutical Co., Ltd. (Osaka, Japan), today announced that SAKURA (Study Assessing double‐masKed Uveitis tReAtment) Study 1, the first of two Global Phase III …